Key result
Despite recent guidelines, the pathophysiology and management of pulmonary hypertension in chronic heart failure remain debated, with no study yet demonstrating the efficacy of any treatment.
This review emphasizes the ongoing diagnostic and therapeutic challenges in managing pulmonary hypertension secondary to chronic heart failure, noting the current lack of proven effective treatments.
No takes yet. Share an insight, caveat, or question.
Confirms PH as prognostic marker in HF; leaves open whether targeted therapies improve outcomes.
Berthelot et al. (2018) conducted a review in Pulmonary hypertension in chronic heart failure. Despite recent guidelines, the pathophysiology and management of pulmonary hypertension in chronic heart failure remain debated, with no study yet demonstrating the efficacy of any treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: